![Bob Disbrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bob Disbrow
Geen lopende functies
Vermogen: 31 M $ op 30-09-2026
Finance
Profiel
Mr. Disbrow joined Haywood in 1999 from First Marathon Securities where he was a director and Branch Manager of the Vancouver office.
A co-founder of First Marathon, he managed the firm's risk capital fund for 10 years and its equity fund for five years.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs 5,11% | 30-09-2025 | 3.368.150 ( 5,11% ) | 31 M $ | 30-09-2026 |
Eerdere bekende functies van Bob Disbrow
| Bedrijven | Functie | Einde |
|---|---|---|
Haywood Securities, Inc.
 Haywood Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Institutionele Verkopen | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Haywood Securities, Inc.
Haywood Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
